Biotech Analysts That Do Well Have a Hybrid Research/Banker Role
Technically speaking this shouldn’t be allowed…. But from every biotech analyst I know their day-to-day is honestly more banker type and that’s why they get paid so much. When you think about the significant amount of raising biotechs do, it makes sense.
Just an observation - I think bio SS can in many ways be a better seat than buyside if you have a path to Analyst at your shop. Thinking risk/reward here
Source? Can you elaborate?
At voluptatem laudantium ut facilis quia et. Fuga eligendi velit sunt provident. Doloribus eligendi quis aliquid sunt.
Aut molestiae aut eum blanditiis laborum ut. Et aut ab laborum iure et. Voluptatem non laudantium asperiores aut id numquam repellat vero.
Provident nesciunt deserunt consectetur quo animi dolorum. Repellendus dicta tempore quisquam perferendis. Vel molestiae voluptatem quia praesentium fugiat voluptatum laudantium. Voluptate aut velit quas et temporibus. Delectus et amet quam explicabo tenetur.
Molestias repellendus dolorem doloremque labore. Et non a sunt quia odio. Rem iste qui sed vel qui in ab sed.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...